AstraZeneca (NYSE: AZN) shares as of market close today will be eligible for a dividend of 48 cents per share. At a price of $49.51 as of 9:35 a.m. ET, the dividend yield is 6.7%. The average volume for AstraZeneca has been 1.8 million shares per day over the past 30 days. AstraZeneca has a market cap of $61.3 billion and is part of the drugs industry. Shares are up 5% year to date as of the close of trading on Monday. EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys dividend stocks that have the potential for a 3% to 4% yield and 10% growth. Get his best picks for less than $50/year. AstraZeneca PLC engages in the discovery, development, and commercialization of prescription medicines for gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology, and infectious diseases worldwide. The company has a P/E ratio of 6.73. Currently there is 1 analyst that rates AstraZeneca a buy, 3 analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates AstraZeneca as a buy. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, largely solid financial position with reasonable debt levels by most measures, attractive valuation levels, growth in earnings per share and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full AstraZeneca Ratings Report now.
- See our top-yielding stocks list.
- See our dividend calendar.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts